Mysid crustaceans as standard models for the screening and testing of endocrine-disrupting chemicals

被引:51
|
作者
Verslycke, Tim
Ghekiere, An
Raimondo, Sandy
Janssen, Colin
机构
[1] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA
[2] Univ Ghent, Lab Environm Toxicol & Aquat Ecol, B-9000 Ghent, Belgium
[3] US EPA, Gulf Ecol Div, Natl Hlth & Environm Effect Res Lab, Gulf Breeze, FL 32561 USA
关键词
invertebrate; endocrine disruption; regulatory testing; standardization; Americamysis bahia;
D O I
10.1007/s10646-006-0122-0
中图分类号
Q14 [生态学(生物生态学)];
学科分类号
071012 ; 0713 ;
摘要
Investigative efforts into the potential endocrine-disrupting effects of chemicals have mainly concentrated on vertebrates, with significantly less attention paid to understanding potential endocrine disruption in the invertebrates. Given that invertebrates account for at least 95% of all known animal species and are critical to ecosystem structure and function, it remains essential to close this gap in knowledge and research. The lack of progress regarding endocrine disruption in invertebrates is largely due to: (1) our ignorance of mode-of-action, physiological control, and hormone structure and function in invertebrates; (2) lack of a standardized invertebrate assay; (3) the irrelevance to most invertebrates of the proposed activity-based biological indicators for endocrine disruptor (ED) exposure (androgen, estrogen, and thyroid); (4) limited field studies. Past and ongoing research efforts using the standard invertebrate toxicity test model, the mysid shrimp, have aimed at addressing some of these issues. The present review serves as an update to a previous publication on the use of mysids for the evaluation of EDs (Verslycke et al. 2004a). It summarizes recent investigative efforts that have significantly advanced our understanding of invertebrate-specific endocrine toxicity, population modeling, field studies, and transgeneration standard test development using the mysid model.
引用
收藏
页码:205 / 219
页数:15
相关论文
共 50 条
  • [21] Endocrine-disrupting chemicals and male health
    Minguez-Alaron, Lidia
    Gaskins, Audrey J.
    Meeker, John D.
    Braun, Joseph M.
    Chavarro, Jorge E.
    FERTILITY AND STERILITY, 2023, 120 (06) : 1138 - 1149
  • [22] The economic legacy of endocrine-disrupting chemicals
    La Merrill, Michele A.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (12): : 961 - 962
  • [23] Effects of Endocrine-Disrupting Chemicals on the Ovary
    Patel, Shreya
    Zhou, Changqing
    Rattan, Saniya
    Flaws, Jodi A.
    BIOLOGY OF REPRODUCTION, 2015, 93 (01)
  • [24] Endocrine-Disrupting Chemicals and Child Health
    Ghassabian, Akhgar
    Vandenberg, Laura
    Kannan, Kurunthachalam
    Trasande, Leonardo
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 573 - 594
  • [25] Endocrine-disrupting chemicals in marine environment
    Preston, MR
    CHEMISTRY OF MARINE WATER AND SEDIMENTS, 2002, : 309 - 324
  • [26] Endocrine-Disrupting Chemicals: Introduction to the Theme
    Lisco, Giuseppe
    Giagulli, Vito Angelo
    Iovino, Michele
    Guastamacchia, Edoardo
    De Pergola, Giovanni
    Triggiani, Vincenzo
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022, 22 (07) : 677 - 685
  • [27] The challenge posed by endocrine-disrupting chemicals
    Ashby, J
    Houthoff, E
    Kennedy, SJ
    Stevens, J
    Bars, R
    Jekat, FW
    Campbell, P
    VanMiller, J
    Carpanini, FM
    Randall, GLP
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 (02) : 164 - 169
  • [28] Endocrine-Disrupting Chemicals in Cosmetics Reply
    Rubin, Courtney Blair
    Brod, Bruce A.
    JAMA DERMATOLOGY, 2020, 156 (05) : 604 - 604
  • [29] Endocrine-disrupting chemicals and child health
    Kiess, Wieland
    Haeussler, Gabriele
    Vogel, Mandy
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (05)
  • [30] Endocrine-disrupting chemicals and skin manifestations
    Ju, Qiang
    Zouboulis, Christos C.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2016, 17 (03): : 449 - 457